Analysts Remain Cautious On Tremor Despite Its Tailwinds, Cut Price Target By 15%
Analysts cut their estimates and price targets on Tremor International Ltd (NASDAQ: TRMR) over a softer outlook amid a challenging macro environment.
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Gainers
AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.
Qualys, ShockWave Medical, News Corporation And Some Other Big Stocks Moving Higher On Tuesday
Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.
Macquarie Downgrades News to Neutral, Lowers Price Target to $21.1
Macquarie analyst Darren Leung downgrades News (NASDAQ:NWSA) from Outperform to Neutral and lowers the price target from $22.3 to $21.1.
Chinese Analyst Provokes Country To Attack Elon Musk’s Popular Starlink Satellite Service
In a paper published by the Beijing Institute of Tracking and Telecommunications Technology, a Chinese researcher urged the Chinese…
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.